U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C29H33ClN6
Molecular Weight 501.066
Optical Activity NONE
Defined Stereocenters 2 / 2
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of Tuspetinib

SMILES

C[C@H]1CN(CC2=CC(=CC(NC3=NC=C(Cl)C(=N3)C4=CNC5=C4C=CC(C)=C5)=C2)C6CC6)C[C@@H](C)N1

InChI

InChIKey=FZLSDZZNPXXBBB-KDURUIRLSA-N
InChI=1S/C29H33ClN6/c1-17-4-7-24-25(12-31-27(24)8-17)28-26(30)13-32-29(35-28)34-23-10-20(9-22(11-23)21-5-6-21)16-36-14-18(2)33-19(3)15-36/h4,7-13,18-19,21,31,33H,5-6,14-16H2,1-3H3,(H,32,34,35)/t18-,19+

HIDE SMILES / InChI

Molecular Formula C29H33ClN6
Molecular Weight 501.066
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 2 / 2
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

Substance Class Chemical
Created
by admin
on Sat Dec 16 14:22:10 GMT 2023
Edited
by admin
on Sat Dec 16 14:22:10 GMT 2023
Record UNII
C0WUS7XXE9
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
Tuspetinib
INN   USAN  
Official Name English
HM43239
Code English
2-Pyrimidinamine, 5-chloro-N-[3-cyclopropyl-5-[[(3R,5S)-3,5-dimethyl-1-piperazinyl]methyl]phenyl]-4-(6-methyl-1H-indol-3-yl)-, rel-
Systematic Name English
TUSPETINIB [USAN]
Common Name English
5-chloro-N-(3-cyclopropyl-5-{[(3R,5S)-dimethylpiperazin-1-yl]methyl}phenyl)-4-(6-methyl-1H-indol-3-yl)pyrimidin-2-amine
Systematic Name English
HM-43239
Code English
tuspetinib [INN]
Common Name English
Code System Code Type Description
FDA UNII
C0WUS7XXE9
Created by admin on Sat Dec 16 14:22:12 GMT 2023 , Edited by admin on Sat Dec 16 14:22:12 GMT 2023
PRIMARY
CAS
2294874-49-8
Created by admin on Sat Dec 16 14:22:12 GMT 2023 , Edited by admin on Sat Dec 16 14:22:12 GMT 2023
PRIMARY
INN
12330
Created by admin on Sat Dec 16 14:22:12 GMT 2023 , Edited by admin on Sat Dec 16 14:22:12 GMT 2023
PRIMARY
NCI_THESAURUS
C165254
Created by admin on Sat Dec 16 14:22:12 GMT 2023 , Edited by admin on Sat Dec 16 14:22:12 GMT 2023
PRIMARY
USAN
KL-178
Created by admin on Sat Dec 16 14:22:12 GMT 2023 , Edited by admin on Sat Dec 16 14:22:12 GMT 2023
PRIMARY
DRUG BANK
DB15343
Created by admin on Sat Dec 16 14:22:12 GMT 2023 , Edited by admin on Sat Dec 16 14:22:12 GMT 2023
PRIMARY
PUBCHEM
135390910
Created by admin on Sat Dec 16 14:22:12 GMT 2023 , Edited by admin on Sat Dec 16 14:22:12 GMT 2023
PRIMARY
Related Record Type Details
TARGET -> INHIBITOR
TARGET -> INHIBITOR
ALSO ACTIVE AGAINST FLT3 ITD and FLT3 D835Y kinases were 1.8 nM and 1.0 nM
IC50
OFF-TARGET->INHIBITOR
TARGET -> INHIBITOR
METABOLIC ENZYME -> INHIBITOR
METABOLIC ENZYME -> SUBSTRATE
SALT/SOLVATE -> PARENT
TARGET -> INHIBITOR
ALSO ACTIVE AGAINST FLT3 ITD and FLT3 D835Y kinases were 1.8 nM and 1.0 nM
SOLVATE->ANHYDROUS
TARGET -> INHIBITOR
METABOLIC ENZYME -> INHIBITOR
METABOLIC ENZYME -> INHIBITOR
TARGET -> INHIBITOR
METABOLIC ENZYME -> SUBSTRATE
Related Record Type Details
ACTIVE MOIETY